New paper published by NRW-junior group leader Dr. Julia Ladewig
A new method could push research into developmental brain disorders an important step forward. This is shown by a recent study at the University of Bonn in which the researchers investigated the development of a rare congenital brain defect. Please find the press release here and a radio report (in German, 06.04.17) here.
Paper published by scientists of the University of Bonn
Find the study "Reciprocal Regulation between Bifunctional miR-9/9 and its Transcriptional Modulator Notch in Human Neural Stem Cell Self-Renewal and Differentiation" published by Beate Roese-Koerner et al here.
Award for NRW Junior Group Leader Dr. Leo Kurian
The German Stem Cell Network has awarded three outstanding stem cell researchers. Dr. Leo Kurian is one of them. To the press release.
New paper published by Natalia Tapia and Hans Schöler
Find the study "Molecular Obstacles to Clinical Translation of iPSCs" published by the stem cell scientists Natalia Tapia and Hans R Schöler here.
Award for NRW Junior Group Leader Dr. Julia Ladewig
The German Stem Cell Network has awarded three outstanding stem cell researchers. Dr. Julia Ladewig from Bonn University is one of them. To the Press release.
German Stem Cell Network Statement on on genetic engineering of the human germline statement
Hans Schöler appointed member of the Board of Directors of the International Society for Stem Cell Research (ISSCR)
Special honor for the Director of the Max Planck Institute of Molecular Biomedicine in Münster. Press release.
Chance discovery. Scientists at the Institute of Reconstructive Neurobiology in Bonn found a new mechanism affecting migration of neurons within the brain. Find the press release here. (DOI: 10.1038/nn.3583)
Report of the European Science Foundation calls for public endorsement and funding
The recent report gives also a good overview about the legislation in Europe for working with human embryonic cells. Report
British stem cell researchers and representatives of patient and science organizations call on MEPs
The goal of the joint statement is to maintain the provision of the current framework for funding stem cell research in the upcoming research program Horizon 2020. Read the full statement
Stem Cell Treatment for Eye Diseases Shows Promise
A treatment for eye diseases that is derived from human embryonic stem cells might have improved the vision of two patients.
The International Society for Stem Cell Research (ISSCR) tries to inform potential users (patients) of stem cell based treatments and suggests guidelines for clinical translation. Read more:
Recent article about unproven therapies in China (Reuters).
European Court of Justice bans patents of procedures based on human embryonic stem cells
After the final decision of the European Court of Justice from October 18, 2011 patents on biomedical inventions which include the use of human embryonic stem cells (hES) can't not be granted any longer.
This is effective no matter if the establishment of hES cells is part of the patent or not or those cells are imported from abroad - the only way it is allowed in Germany for example. Researchers interprete this decision as a set back for translation orientated research. More than 100 patents within Europe are affected by this.
Research Map NRW:
Thanks to various research approaches, a wide spectrum of scientific research into adult and embryo stem cells is covered in North Rhine Westphalia (NRW). The Stem Cell Network includes research facilities in Aachen, Bielefeld, Bochum, Bonn, Cologne, Düsseldorf, Essen, Münster and Witten/Herdecke. In addition, work on ethical, legal and sociological aspects of stem cell research is being conducted by various faculties at universities in Bochum, Bonn, Cologne, Duisburg, Düsseldorf, Essen, Hagen and Münster. For an overview of all these facilities, check out the Research Map NRW.